NASDAQ:ANAB - AnaptysBio Price Target & Analyst Ratings

-0.96 (-1.78 %)
(As of 07/18/2019 02:00 PM ET)
Today's Range
Now: $52.95
50-Day Range
MA: $63.13
52-Week Range
Now: $52.95
Volume147,745 shs
Average Volume371,219 shs
Market Capitalization$1.43 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

AnaptysBio (NASDAQ:ANAB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for AnaptysBio in the last 12 months. Their average twelve-month price target is $114.3636, suggesting that the stock has a possible upside of 115.98%. The high price target for ANAB is $153.00 and the low price target for ANAB is $74.00. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.732.912.912.91
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $114.3636$127.6364$127.6364$128.7273
Price Target Upside: 115.98% upside82.47% upside68.56% upside78.94% upside

AnaptysBio (NASDAQ:ANAB) Consensus Price Target History

AnaptysBio (NASDAQ:ANAB) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/24/2019HC WainwrightSet Price TargetBuy$126.00HighView Rating Details
6/24/2019SunTrust BanksLower Price TargetBuy$125.00 ➝ $93.00HighView Rating Details
6/21/2019Stifel NicolausDowngradeBuy ➝ Hold$124.00 ➝ $74.00HighView Rating Details
6/21/2019Credit Suisse GroupDowngradeOutperform ➝ Neutral$137.00 ➝ $79.00HighView Rating Details
4/2/2019Cantor FitzgeraldSet Price TargetBuy$140.00HighView Rating Details
3/1/2019WedbushReiterated RatingOutperformMediumView Rating Details
2/22/2019GuggenheimInitiated CoverageBuy$135.00HighView Rating Details
11/21/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$115.00HighView Rating Details
8/15/2018JMP SecuritiesLower Price TargetMarket Outperform ➝ Buy$180.00 ➝ $153.00LowView Rating Details
8/8/2018Royal Bank of CanadaReiterated RatingHold$84.00LowView Rating Details
8/7/2018Jefferies Financial GroupReiterated RatingBuy$121.00LowView Rating Details
1/19/2018Robert W. BairdReiterated RatingBuy$81.00 ➝ $144.00HighView Rating Details
(Data available from 7/18/2017 forward)
This page was last updated on 7/18/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel